Cargando…

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

The main protease, M(pro) (or 3CL(pro)) in SARS-CoV-2 is a viable drug target because of its essential role in the cleavage of the virus polypeptide. Feline infectious peritonitis, a fatal coronavirus infection in cats, was successfully treated previously with a prodrug GC376, a dipeptide-based prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vuong, Wayne, Khan, Muhammad Bashir, Fischer, Conrad, Arutyunova, Elena, Lamer, Tess, Shields, Justin, Saffran, Holly A., McKay, Ryan T., van Belkum, Marco J., Joyce, Michael A., Young, Howard S., Tyrrell, D. Lorne, Vederas, John C., Lemieux, M. Joanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453019/ https://www.ncbi.nlm.nih.gov/pubmed/32855413 http://dx.doi.org/10.1038/s41467-020-18096-2

Ejemplares similares

Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
por: Vuong, Wayne, et al.
Publicado: (2020)

N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 M(pro) Dimer
por: Arutyunova, Elena, et al.
Publicado: (2021)

Improved SARS-CoV-2 M(pro) inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies
por: Vuong, Wayne, et al.
Publicado: (2021)

Crystallization of Feline Coronavirus M(pro) With GC376 Reveals Mechanism of Inhibition
por: Lu, Jimmy, et al.
Publicado: (2022)

SARS-CoV-2 M(pro) Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals
por: Chen, Sizhu Amelia, et al.
Publicado: (2023)

Simplified cloning and isolation of peptides from “sandwiched” SUMO-peptide-intein fusion proteins
por: Lamer, Tess, et al.
Publicado: (2023)

SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1
por: Law, John Lok Man, et al.
Publicado: (2021)

Crystallization and preliminary crystallographic study of Feline infectious peritonitis virus main protease in complex with an inhibitor
por: Wang, Jinshan, et al.
Publicado: (2014)

Insights into the catalytic properties of the mitochondrial rhomboid protease PARL
por: Lysyk, Laine, et al.
Publicado: (2021)

Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection
por: Duncan, Joseph K. Sampson, et al.
Publicado: (2023)

Draft Genome Sequences of Paenibacillus polymyxa NRRL B-30509 and Paenibacillus terrae NRRL B-30644, Strains from a Poultry Environment That Produce Tridecaptin A and Paenicidins
por: van Belkum, Marco J., et al.
Publicado: (2015)

BDA‐410 inhibits SARS‐CoV‐2 main protease activity and viral replication in mammalian cells
por: Schwake, Christopher, et al.
Publicado: (2022)

Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor
por: Perera, Krishani Dinali, et al.
Publicado: (2019)

Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3
por: Yoshikawa, Rokusuke, et al.
Publicado: (2017)

Protease inhibitors broadly effective against feline, ferret and mink coronaviruses
por: Perera, Krishani Dinali, et al.
Publicado: (2018)

Structural dynamics of COVID-19 main protease
por: Shekaari, Ashkan, et al.
Publicado: (2021)

Quaternary Structure of the SARS Coronavirus Main Protease
por: Chang, Gu-Gang
Publicado: (2009)

Two Inhibitors Against the 3C-Like Proteases of Swine Coronavirus and Feline Coronavirus
por: Zhou, Mengxin, et al.
Publicado: (2021)

Time-Course Analysis of Main Markers of Primary Infection in Cats with the Feline Immunodeficiency Virus
por: Ribba, B., et al.
Publicado: (2012)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

Individual and common inhibitors of coronavirus and picornavirus main proteases
por: Kuo, Chih-Jung, et al.
Publicado: (2009)

Molecular modeling evaluation of the binding effect of five protease inhibitors to COVID-19 main protease
por: Liu, Jian, et al.
Publicado: (2021)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease
por: Kim, Yunjeong, et al.
Publicado: (2013)

Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis
por: Sharun, Khan, et al.
Publicado: (2020)

Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2
por: Shahbaz, Shima, et al.
Publicado: (2021)

Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
por: Yang, Haitao, et al.
Publicado: (2005)

The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020)

Topological analysis of SARS CoV-2 main protease
por: Estrada, Ernesto
Publicado: (2020)

Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021)

Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)

Allosteric Hotspots in the Main Protease of SARS-CoV-2
por: Strömich, Léonie, et al.
Publicado: (2022)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

Impact of Drug Repurposing on SARS-Cov-2 Main Protease
por: Ndagi, Umar, et al.
Publicado: (2023)

Virtual Screening of Artemisia annua Phytochemicals as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme
por: Miandad, Khalid, et al.
Publicado: (2022)

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
por: Zhao, Yao, et al.
Publicado: (2021)

Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
por: Hemmati, Seyed Ali, et al.
Publicado: (2022)

A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism
por: Ho, Chien-Yi, et al.
Publicado: (2022)

Feline Infectious Peritonitis (Feline Coronavirus)
por: Sherding, Robert G.
Publicado: (2006)

Identification of SARS-CoV-2 Main Protease Inhibitors from a Library of Minor Cannabinoids by Biochemical Inhibition Assay and Surface Plasmon Resonance Characterized Binding Affinity
por: Liu, Chang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_50tknd2nk82kulgie75njp2110